Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and earnings for the second quarter of 2023.
- Second-quarter revenue came in at $1.61 billion, which is up 1% year-over-year
- Earnings per share increased to $0.95 in the June quarter from $0.92 last year
- Adjusted earnings were $1.31 per share in Q2, compared to $1.25 per share in the second quarter of 2022
- The company reported second-quarter adjusted EBITDA of $530 million, which is up 4% annually
- The management expects full-year 2023 revenue to be in the range of $6.25 billion to $6.45 billion
- Adjusted EBITDA margin for 2023 is currently expected to be between 31.5% and 33.0%
Most Popular
Key metrics from Kroger’s (KR) Q3 2025 earnings results
The Kroger Co. (NYSE: KR) reported its third quarter 2025 earnings results today. Total company sales rose to $33.9 billion from $33.6 billion in the same period last year. Identical
Dollar General (DG) Q3 2025 Earnings: Key financials and quarterly highlights
Dollar General Corporation (NYSE: DG) reported its third quarter 2025 earnings results today. Net sales increased 4.6% year-over-year to $10.65 billion. Same-store sales increased 2.5%. Net income was $282.7 million, or
HRL Earnings: All you need to know about Hormel Foods’ Q4 2025 earnings results
Hormel Foods Corporation (NYSE: HRL) reported its fourth quarter 2025 earnings results today. Net sales increased 1.5% year-over-year to $3.18 billion. Organic sales were up 2%. Net loss attributable to Hormel
